Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis

被引：0
|
作者：
de Groot, K [1 ]
Jayne, DRW [1 ]
Tesar, V [1 ]
Savage, COS [1 ]
机构：
[1] Med Sch Hannover, Nephrology, Hannover, Germany
来源：
KIDNEY & BLOOD PRESSURE RESEARCH | 2005年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [21] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [22] A RANDOMIZED CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE FOR INDUCTION THERAPY IN ANCA ASSOCIATED SYSTEMIC VASCULITIS WITH RENAL INVOLVEMENT
    Chen, Nan
    Li, Xin
    Zhang, Wen
    Shen, Pingyan
    Yu, Haijing
    Chen, Yongxi
    Ren, Hong
    Ni, Liyan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 61 - 62
  • [23] PULSE VERSUS DAILY ORAL CYCLOPHOSPHAMIDE IN ANCA-ASSOCIATED VASCULITISWITH RENAL INVOLVEMENT: A SINGLE CENTER EXPERIENCE
    Dias, Joana Pereira
    Vaz Da Rocha Paes de Faria, Maria Victoria
    Almeida, Catarina
    Alferes, Daniela
    Carmo, Rute
    Santos, Maria Clara
    Almeida, Clara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I334 - I334
  • [24] A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
    Smith, R.
    Jayne, D.
    Merkel, P. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 19 - 20
  • [25] A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
    Smith, Rona
    Jayne, David
    Merkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2185 - 2185
  • [26] A Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-associated Vasculitis and Relapsing Disease
    Smith, Rona
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Plasma exchange and low cyclophosphamide dose in induction treatment of ANCA-associated systemic vasculitis
    Szpirt, Wladimir M.
    Krarup, Elisabeth
    Egfjord, Martin
    APMIS, 2009, 117 : 75 - 75
  • [28] Induction and maintenance therapy in ANCA-associated systemic vasculitis
    Menahem, Solomon
    Hiremagalur, Balaji
    Mudge, David
    Toussaint, Nigel
    Walters, Giles
    NEPHROLOGY, 2008, 13 : S24 - S36
  • [29] Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
    Timlin, H.
    Lee, S. M.
    Manno, R. L.
    Seo, P.
    Geetha, Duvura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 67 - 69
  • [30] Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly
    Faten Aqeel
    Lillian Xu
    Antonio Salas
    Yumeng Wen
    Shaker M. Eid
    Duvuru Geetha
    Clinical Rheumatology, 2023, 42 : 2427 - 2435
12345